At the end of June 2022, I had the chance to present my work at the British Neuro-Oncology Society (BNOS) Conference, in partnership with the Computational Oncology Laboratory. Now that I am back from Liverpool, where the conference took place, I thought to write quick a summary of my analysis on the end-of-life care for patients diagnosed with a primary brain tumour in England between 2013 and 2018.
Every year, 12,000 new cases of brain tumours are diagnosed in the UK, making brain tumours the 9th most common cancer. Prognosis is often inauspicious, with only 12% of patients surviving 5 years or more.
Research on end-of-life care is rare and the national picture is even rarer. We know that usually people with cancer prefer to die at home, although this is not always the case, and a high number of patients continue to die in hospital or hospices. We are interested in understanding what factors affect the location of death and if having treatment within a few months before death affect the location of death.